Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration.

The pulmonary route represents one of the most important portals of entry for nanoparticles into the body. However, the in vivo interactions of nanoparticles with biomolecules of the lung have not been sufficiently studied. Here, using an established mouse model of pharyngeal aspiration of single-walled carbon nanotubes (SWCNTs), we recovered SWCNTs from the bronchoalveolar lavage fluid (BALf), purified them from possible contamination with lung cells, and examined the composition of phospholipids adsorbed on SWCNTs by liquid chromatography mass spectrometry (LC-MS) analysis. We found that SWCNTs selectively adsorbed two types of the most abundant surfactant phospholipids: phosphatidylcholines (PC) and phosphatidylglycerols (PG). Molecular speciation of these phospholipids was also consistent with pulmonary surfactant. Quantitation of adsorbed lipids by LC-MS along with the structural assessments of phospholipid binding by atomic force microscopy and molecular modeling indicated that the phospholipids (∼108 molecules per SWCNT) formed an uninterrupted "coating" whereby the hydrophobic alkyl chains of the phospholipids were adsorbed onto the SWCNT with the polar head groups pointed away from the SWCNT into the aqueous phase. In addition, the presence of surfactant proteins A, B, and D on SWCNTs was determined by LC-MS. Finally, we demonstrated that the presence of this surfactant coating markedly enhanced the in vitro uptake of SWCNTs by macrophages. Taken together, this is the first demonstration of the in vivo adsorption of the surfactant lipids and proteins on SWCNTs in a physiologically relevant animal model.

[1]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[2]  Jian Qin,et al.  The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. , 2006, Nano letters.

[3]  J. Pugin,et al.  Cytokine balance in the lungs of patients with acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.

[4]  Ji-Ho Park,et al.  Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. , 2009, Biomaterials.

[5]  C Hermans,et al.  Lung epithelium-specific proteins: characteristics and potential applications as markers. , 1999, American journal of respiratory and critical care medicine.

[6]  James L. McGrath,et al.  The influence of protein adsorption on nanoparticle association with cultured endothelial cells. , 2009, Biomaterials.

[7]  Simon Watkins,et al.  Oxidative lipidomics of hyperoxic acute lung injury: mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[8]  J. Johansson,et al.  Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. J. Batenburg,et al.  The Pulmonary Surfactant System , 1994 .

[10]  Peter Gehr,et al.  Pulmonary surfactant: Surface properties and function of alveolar and airway surfactant , 1992 .

[11]  P. Nikolaev,et al.  Purification Procedures for Single-Wall Carbon Nanotubes , 2001 .

[12]  Mark D. Hoover,et al.  Efficacy of a Technique for Exposing the Mouse Lung to Particles Aspirated from the Pharynx , 2003, Journal of toxicology and environmental health. Part A.

[13]  Bengt Fadeel,et al.  Impaired Clearance and Enhanced Pulmonary Inflammatory/Fibrotic Response to Carbon Nanotubes in Myeloperoxidase-Deficient Mice , 2012, PloS one.

[14]  S. Gharib,et al.  Of Mice and Men: Comparative Proteomics of Bronchoalveolar Fluid. , 2009, ATS 2009.

[15]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[16]  C. D. Scott,et al.  Iron catalyst chemistry in modeling a high-pressure carbon monoxide nanotube reactor. , 2003, Journal of nanoscience and nanotechnology.

[17]  Iseult Lynch,et al.  What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.

[18]  R. Zhou,et al.  Binding of blood proteins to carbon nanotubes reduces cytotoxicity , 2011, Proceedings of the National Academy of Sciences.

[19]  G. Freeman,et al.  Structures of T cell immunoglobulin mucin protein 4 show a metal-Ion-dependent ligand binding site where phosphatidylserine binds. , 2007, Immunity.

[20]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[21]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[22]  Ronald J. Moore,et al.  Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size , 2011, Proteomics.

[23]  Judith Klein-Seetharaman,et al.  Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. , 2010, Nature nanotechnology.

[24]  L. Gluck,et al.  Phosphatidylglycerol in lung surfactant. III. Possible modifier of surfactant function. , 1976, Journal of lipid research.

[25]  Mark S.P. Sansom,et al.  Carbon nanotube/detergent interactions via coarse-grained molecular dynamics. , 2007, Nano letters.

[26]  Hak Soo Choi,et al.  Rapid translocation of nanoparticles from the lung airspaces to the body , 2010, Nature Biotechnology.

[27]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[28]  S. K. Sundaram,et al.  Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  J. Beck,et al.  The Pulmonary Surfactant System in Pneumocystis Pneumonia , 2004 .

[30]  M. Beers,et al.  Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. , 2006, Microbes and infection.

[31]  W. Kreyling,et al.  The influence of pulmonary surfactant on nanoparticulate drug delivery systems. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  Z. Sever-Chroneos,et al.  Pulmonary Surfactant: An Immunological Perspective , 2009, Cellular Physiology and Biochemistry.

[33]  D. Voelker,et al.  Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus–induced inflammation and infection , 2009, Proceedings of the National Academy of Sciences.

[34]  P. Baron,et al.  Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[35]  Sara Linse,et al.  Complete high‐density lipoproteins in nanoparticle corona , 2009, The FEBS journal.

[36]  M. Schlame,et al.  Alveolar surfactant subfractions differ in their lipid composition. , 1995, The international journal of biochemistry & cell biology.

[37]  H. Haagsman,et al.  The Pulmonary Surfactant System: Biochemical and Clinical Aspects , 1997, Lung.

[38]  Minnamari Vippola,et al.  Proteomic characterization of engineered nanomaterial-protein interactions in relation to surface reactivity. , 2011, ACS nano.

[39]  Samuel L. C. Moors,et al.  Molecular dynamics study of dipalmitoylphosphatidylcholine lipid layer self-assembly onto a single-walled carbon nanotube , 2009 .

[40]  Wen-chao Song,et al.  Complement and its role in innate and adaptive immune responses , 2010, Cell Research.

[41]  H. Bayır,et al.  Phosphatidylserine Targets Single-Walled Carbon Nanotubes to Professional Phagocytes In Vitro and In Vivo , 2009, PloS one.

[42]  A. Nel,et al.  Oxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. , 2009, Journal of proteome research.

[43]  W. Bartsch,et al.  The surfactant system of the adult lung: physiology and clinical perspectives , 1992, The clinical investigator.

[44]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[45]  Peter Wick,et al.  The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry , 2010, Journal of nanobiotechnology.

[46]  R. Veldhuizen,et al.  The role of lipids in pulmonary surfactant. , 1998, Biochimica et biophysica acta.

[47]  Stanley L. Hazen,et al.  Oxidized phosphatidylserine–CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells , 2006 .

[48]  D. Grigoryev,et al.  1‐DE MS and 2‐D LC‐MS analysis of the mouse bronchoalveolar lavage proteome , 2005, Proteomics.

[49]  K. Yoneda,et al.  Effect of rat surfactant lipids on complement and Fc receptors of macrophages , 1986, Infection and immunity.